iGMDRD97
Canonical SMILES: CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
InChI: InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)
InChI Key: NAVMQTYZDKMPEU-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameBexarotene CHEMBLCHEMBL1023 Pubchem CID82146 KEGG Drug IDD03106 DRUGBANK IDDB00307 Drug StatusAlone Drug targets (TTD)DAP000276 Drug TypeSmall Molecule |
Drug Class:
Anticarcinogenic AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCytochrome P-450 CYP3A InducersCytochrome P-450 Enzyme InducersHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicImmunosuppressive AgentsMyelosuppressive AgentsNaphthalenesPolycyclic CompoundsPolycyclic Hydrocarbons, AromaticProtective AgentsRetinoic Acid DerivativesRetinoidsSpecialty Uses of ChemicalsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Bexarotene
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |